Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Breast Neoplasms 49Lung Neoplasms 30Colorectal Neoplasms 23Prostatic Neoplasms 20Colonic Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Rectal Neoplasms 13Neoplasms 13Uterine Cervical Neoplasms 12Endometrial Neoplasms 9Depression 9Unspecified Adult Solid Tumor, Protocol Specific 8Fatigue 8Anxiety Disorders 8Urinary Bladder Neoplasms 7Lymphoma 7Breast Carcinoma In Situ 7Pancreatic Neoplasms 6Pain 6Ovarian Neoplasms 6Hematologic Neoplasms 6Obesity 5Melanoma 5Hematopoietic and Lymphatic System Neoplasm 5Carcinoma, Ovarian Epithelial 5Vulvar Neoplasms 4Papillomavirus Infections 4Neoplasm Metastasis 4Multiple Myeloma 4Leukemia, Myeloid, Acute 4

Interventions

Early Intervention, Educational 1Diet, Mediterranean 1Diet, Ketogenic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Growth Hormone-Secreting Pituitary Adenoma × Early Intervention, Educational × Clear all
NCT01775332 2015-07-31

Interdisciplinary Pituitary Disorders Centre of Excellence: Assessment of Patient Education Tools

Unity Health Toronto

Phase NA Unknown
60 enrolled
Endocrine

Gigantism, Pituitary Neoplasms, Prolactinoma, Growth Hormone-Secreting Pituitary Adenoma, ACTH-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡